Demand for Anthropic's IPO revives the AI rally, but a market propped up by a single bloc is fragile

By Bloomberg · November 11, 2026.

Anthropic's initial public offering (IPO) has drawn orders for several times the number of shares available, Bloomberg has learned. That puts it on track to potentially become the largest first-time share sale in history. Bloomberg's report does not give the exact level of demand or the size of the deal.

The market reacted immediately. According to Bloomberg, the Nasdaq 100 rose enough to wipe out all the losses from late last week's sharp sell-off, and the Stoxx Europe 600 closed at a record high. The other factor was CoreWeave, a heavily indebted “neocloud” (a cloud computing provider specializing in AI), which raised its annual revenue forecast above Wall Street's expectations.

The context matters. Bloomberg explains that the previous week, investors had been spooked by the data center buildout that underpins all of AI. In other words, the rebound doesn't reflect a change in fundamentals. It reflects relief that two demand signals arrived right after the scare.

For industry context, other Bloomberg coverage describes the IPO as the “Jenga block” holding up the next phase of the AI cycle. More broadly, a financial outlet using that image shows that the market sees this deal as a barometer for the entire sector.

**Our take.** The argument is simple: if a single IPO can lift an index, that says more about how fragile the narrative is than how solid it is. An oversubscribed IPO shows appetite, not profitability. Orders capture enthusiasm, and enthusiasm is exactly what evaporated a week ago amid concerns about data centers.

The financial details add nuance. The source provides no figures on Anthropic's margins or compute costs. Demand for shares is one thing; margin per token is another. The metric that will matter in quarterly results is inference and energy efficiency, not how many times the offering was covered.

The day's two main players should also be kept apart. CoreWeave offers a more tangible signal: demand for its capacity keeps growing, albeit with high debt, and that leverage is exactly what becomes frightening when sentiment shifts. Anthropic offers the opposite signal: plentiful capital willing to fund the frontier. Each depends on the other. If capital stops flowing, leveraged neoclouds are the first to feel it.

In the long run, the outlook is favorable. An IPO of this size puts a lot of capital behind the labs pursuing the breakthroughs that matter most to us: medicine, science and, eventually, abundant resources. Funding that race with public, transparent money and auditable accounts is better than doing it in the dark through private rounds.

In the short term, though, the risk is the usual one: a cycle of euphoria leads to overinvestment in infrastructure, and the correction that follows takes down those who financed compute with debt. Anyone buying Anthropic shares should do so with the next decade in mind, not the next trading session.